Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: Systematic review and meta-analysis.-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: Systematic review and meta-analysis.

Published:2022-07 Issue:1 Volume:166 Page:181-187
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Guida Francesco,Dioun Shayan,Fagotti Anna,Melamed Alexander,Grossi Adriano,Scambia Giovanni,Wright Jason D.,Tergas Ana I.

Funder

National Center for Advancing Translational Sciences

Rutgers, The State University of New Jersey

National Institutes of Health

Conquer Cancer Foundation

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference29 articles.

1. Ovarian cancer statistics, 2018, CA;Torre;Cancer J. Clin.,2018

2. SEER Cancer Statistics Review, 1975–2016,2016

3. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis;Bristow;J. Clin. Oncol.,2002

4. Surgical cytoreduction for recurrent epithelial ovarian cancer;Al Rawahi;Cochrane Database Syst. Rev.,2013

5. Randomized controlled phase III study evaluating the impact of secondary cytoreductive surgery in recurrent ovarian cancer: AGO DESKTOP III/ENGOT ov20;Du Bois;J. Clin. Oncol.,2017

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular biology as a driver in therapeutic choices for ovarian cancer;International Journal of Gynecologic Cancer;2024-08-28

2. New immune phenotypes for treatment response in high-grade serous ovarian carcinoma patients;Frontiers in Immunology;2024-06-14

3. Cancer-Associated Fibroblast Mimetic AIE Probe for Precision Imaging-Guided Full-Cycle Management of Ovarian Cancer Surgery;Analytical Chemistry;2023-09-28

4. Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR;Medicina;2023-03-19

5. Recurrent High Grade Serous Ovarian Cancer Management;Ovarian Cancer;2022-08-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3